Stay updated on PRTX-100-202 Study in ITP Clinical Trial
Sign up to get notified when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.

Latest updates to the PRTX-100-202 Study in ITP Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new unified 'Locations' section was added, listing study sites in California, Massachusetts, Michigan, New York, Ohio, AB, and Leichester, with the revision updated to v3.3.3. The old location-specific subpages and the 'HHS Vulnerability Disclosure' link were removed, reflecting the updated structure.SummaryDifference0.9%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoval of the government funding status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions were detected. The Study Details page content remains unchanged, including the title, objectives, eligibility criteria, and locations.SummaryDifference0.3%

- Check92 days agoChange Detected- Added a government-status notice about potential delays and operating status (high importance for time-sensitive information). - Updated revision tag to v3.2.0 (minor, alignment with versioning). - Removed a specific topic/resource, Autoimmune thrombocytopenic purpura, from the Genetic and Rare Diseases Information Center (moderate impact due to content removal).SummaryDifference4%

- Check99 days agoChange DetectedVersion update from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to PRTX-100-202 Study in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRTX-100-202 Study in ITP Clinical Trial page.